NLRP3 and Myocardial fibrosis: In vivo experimental results showed that LGZGD could significantly improve cardiac function, alleviate myocardial fibrosis, reduce the level of inflammatory factors, and inhibit the activation of NLRP3/Caspase-1/GSDMD signaling pathway.